In humans, circAβ-a from the APP gene translates into an Aβ-containing peptide that aggregates and drives amyloid-β (Aβ) deposition, providing an alternative pathway for Alzheimer’s disease (AD) pathogenesis (Mo et al., 2020). This evidence concerns the gene APP and Alzheimer disease.